- Email: [email protected]
The Top Ten
european urology 49 (2006) 588
available at www.sciencedirect.com journal homepage: www.europeanurology.com
The Top Ten Selection of readers’ most popular articles NOVEMBER (2005) Welcome to a new regular section of the journal that will highlight the ‘Top Ten’ most read articles. Each list is compiled with a delay of four months from publication. If you only have a few minutes reading time each day – then these are the articles you should look at. 1 Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement Schro¨der, F.H.; Roobol, M.J.; Boeve´, E.R.; de Mutsert, R., Zuijdgeest-van Leeuwen, S.D.; Kersten, I.; Wildhagen, M.F.; van Helvoort, A. European Urology 2005;48(6):922–31. 2 EAU Guidelines on Prostate Cancer Aus, G.; Abbou, C.C.; Bolla, M.; Heidenreich, A.; Schmid, H.-P.; van Poppel, H.; Wolff, J.; Zattoni, F. European Urology 2005;48(4):546–51. 3 Risks and Benefits of Hormonal Manipulation as Monotherapy or Adjuvant Treatment in Localised Prostate Cancer Abrahamsson, P.-A.; Anderson, J.; Boccon-Gibod, L.; Schulman, C.; Studer, U.E.; Wirth, M. European Urology 2005;48(6):900–5. 4 Evaluating Preference Trials of Oral Phosphodiesterase 5 Inhibitors for Erectile Dysfunction Mulhall, J.P.; Montorsi, F. European Urology 2005;49(1):30–7. 5 Guidelines on Testicular Cancer Albers, P.; Albrecht, W.; Algaba, F.; Bokemeyer, C.; Cohn-Cedermark, G.; Horwich, A.; Klepp, O.; Laguna, M.P.; Pizzocaro, G. European Urology 2005;48(6):885–94.
0302-2838/$ – see front matter
doi:10.1016/S0302-2838(06)00138-2
6 Androgen Receptor and TGFbeta1/Smad Signaling are Mutually Inhibitory in Prostate Cancer van der Poel, H.G. European Urology 2005;48(6):1051–8. 7 The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis Chapple, C.; Khullar, V.; Gabriel, Z.; Dooley, J.A. European Urology 2005;48(1):5–26. 8 A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial for the STAR study group, Chapple, C.R.; Martinez-Garcia, R.; Selvaggi, L.; Toozs-Hobson, P.; Warnack, W.; Drogendijk, T.; Wright, D.M.; Bolodeoku, J. European Urology 2005;48(3):464–70. 9 EAU Guidelines on Male Infertility The EAU Working Group on Male Infertility, Dohle, G.R.; Colpi, G.M.; Hargreave, T.B.; Papp, G.K.; Jungwirth, A.; Weidner, W. European Urology 2005;48(5):703–11. 10 Adjuvant and Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: Literature Review Pectasides, D.; Pectasides, M.; Nikolaou, M. European Urology 2005;48(1):60–8.
available at www.sciencedirect.com journal homepage: www.europeanurology.com
The Top Ten Selection of readers’ most popular articles NOVEMBER (2005) Welcome to a new regular section of the journal that will highlight the ‘Top Ten’ most read articles. Each list is compiled with a delay of four months from publication. If you only have a few minutes reading time each day – then these are the articles you should look at. 1 Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement Schro¨der, F.H.; Roobol, M.J.; Boeve´, E.R.; de Mutsert, R., Zuijdgeest-van Leeuwen, S.D.; Kersten, I.; Wildhagen, M.F.; van Helvoort, A. European Urology 2005;48(6):922–31. 2 EAU Guidelines on Prostate Cancer Aus, G.; Abbou, C.C.; Bolla, M.; Heidenreich, A.; Schmid, H.-P.; van Poppel, H.; Wolff, J.; Zattoni, F. European Urology 2005;48(4):546–51. 3 Risks and Benefits of Hormonal Manipulation as Monotherapy or Adjuvant Treatment in Localised Prostate Cancer Abrahamsson, P.-A.; Anderson, J.; Boccon-Gibod, L.; Schulman, C.; Studer, U.E.; Wirth, M. European Urology 2005;48(6):900–5. 4 Evaluating Preference Trials of Oral Phosphodiesterase 5 Inhibitors for Erectile Dysfunction Mulhall, J.P.; Montorsi, F. European Urology 2005;49(1):30–7. 5 Guidelines on Testicular Cancer Albers, P.; Albrecht, W.; Algaba, F.; Bokemeyer, C.; Cohn-Cedermark, G.; Horwich, A.; Klepp, O.; Laguna, M.P.; Pizzocaro, G. European Urology 2005;48(6):885–94.
0302-2838/$ – see front matter
doi:10.1016/S0302-2838(06)00138-2
6 Androgen Receptor and TGFbeta1/Smad Signaling are Mutually Inhibitory in Prostate Cancer van der Poel, H.G. European Urology 2005;48(6):1051–8. 7 The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis Chapple, C.; Khullar, V.; Gabriel, Z.; Dooley, J.A. European Urology 2005;48(1):5–26. 8 A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial for the STAR study group, Chapple, C.R.; Martinez-Garcia, R.; Selvaggi, L.; Toozs-Hobson, P.; Warnack, W.; Drogendijk, T.; Wright, D.M.; Bolodeoku, J. European Urology 2005;48(3):464–70. 9 EAU Guidelines on Male Infertility The EAU Working Group on Male Infertility, Dohle, G.R.; Colpi, G.M.; Hargreave, T.B.; Papp, G.K.; Jungwirth, A.; Weidner, W. European Urology 2005;48(5):703–11. 10 Adjuvant and Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: Literature Review Pectasides, D.; Pectasides, M.; Nikolaou, M. European Urology 2005;48(1):60–8.